Clinical Trial Update: Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer [NA]

View source ↗

Summary

A Ballad Health-sponsored clinical trial is evaluating longitudinal plasma PD-L1 testing in non-small cell lung cancer patients treated with immunotherapy. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Ballad Health | Conditions: Lung Cancer (NSCLC) | NA | Status: RECRUITING